Volasertib (BI6727) Mechanism of Action: PLK1 Inhibition in Leukemia Cell Research

Volasertib (BI6727) MOA:Targeting PLK1/Cell Cycle for Acute Myeloid Leukemia

🎯 check Volasertib (BI6727) product page

Volasertib (BI6727) is a potent, highly specific, ATP-competitive PLK1 inhibitor. It affects PI3K/AKT/mTOR and AURKA-PLK1-FOXM1 signaling pathways by inducing G2/M cell cycle arrest, promoting DNA damage, and downregulating MYC, effectively inhibiting tumor cell proliferation and promoting apoptosis.

Primary Applications and Mechanism of Action